Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Schmitz

Showing results (221-230 of 239) with videos related to

Pageof 24
Sort By:
American Journal of Medical Genetics|July 25, 1997
Allelic association of juvenile absence epilepsy with a GluR5 kainate receptor gene (GRIK1) polymorphismT Sander, T Hildmann, R Kretz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 12, 2024
Long-term follow-up of a randomized, double-blind, phase III, multi-centre study to evaluate the safety and efficacy of field-directed photodynamic therapy (PDT) of mild to moderate actinic keratosis using BF-200 ALA versus placebo and the BF-RhodoLED® lampU Reinhold, W G Philipp-Dormston, T Dirschka, et al.
European Journal of Neurology|May 29, 2009
Health-related quality of life measures and psychiatric comorbidity in patients with migraineM Mula, M Viana, R Jauch, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 20, 2018
A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosisT Dirschka, S Ekanayake-Bohlig, R Dominicus, et al.
Acta Neurologica Scandinavica|October 15, 2014
Epilepsy in the elderly: restrictions, fears, and quality of lifeT W May, M Pfäfflin, C Brandt, et al.
The British Journal of Dermatology|February 28, 2016
A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lampU Reinhold, T Dirschka, R Ostendorf, et al.
Seizure|June 18, 2026
Defining seizure freedom in epilepsy: a pragmatic literature reviewP Boon, B Schmitz, P House, et al.
Acta Neurologica Scandinavica|February 6, 2014
Epilepsy in the elderly: comparing clinical characteristics with younger patientsH Stefan, T W May, M Pfäfflin, et al.
Seizure|June 25, 2026
Unlocking seizure freedom: A European Delphi panel study on the clinical, humanistic, and economic value of seizure control in epilepsyP Boon, B Schmitz, P House, et al.
Neurology|September 26, 1997
Refined mapping of the epilepsy susceptibility locus EJM1 on chromosome 6T Sander, B Bockenkamp, T Hildmann, et al.
Pageof 24

Showing results (221-230 of 239) with videos related to

Sort By:
Pageof 24
American Journal of Medical Genetics|July 25, 1997
Allelic association of juvenile absence epilepsy with a GluR5 kainate receptor gene (GRIK1) polymorphismT Sander, T Hildmann, R Kretz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 12, 2024
Long-term follow-up of a randomized, double-blind, phase III, multi-centre study to evaluate the safety and efficacy of field-directed photodynamic therapy (PDT) of mild to moderate actinic keratosis using BF-200 ALA versus placebo and the BF-RhodoLED® lampU Reinhold, W G Philipp-Dormston, T Dirschka, et al.
European Journal of Neurology|May 29, 2009
Health-related quality of life measures and psychiatric comorbidity in patients with migraineM Mula, M Viana, R Jauch, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 20, 2018
A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosisT Dirschka, S Ekanayake-Bohlig, R Dominicus, et al.
Acta Neurologica Scandinavica|October 15, 2014
Epilepsy in the elderly: restrictions, fears, and quality of lifeT W May, M Pfäfflin, C Brandt, et al.
The British Journal of Dermatology|February 28, 2016
A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lampU Reinhold, T Dirschka, R Ostendorf, et al.
Seizure|June 18, 2026
Defining seizure freedom in epilepsy: a pragmatic literature reviewP Boon, B Schmitz, P House, et al.
Acta Neurologica Scandinavica|February 6, 2014
Epilepsy in the elderly: comparing clinical characteristics with younger patientsH Stefan, T W May, M Pfäfflin, et al.
Seizure|June 25, 2026
Unlocking seizure freedom: A European Delphi panel study on the clinical, humanistic, and economic value of seizure control in epilepsyP Boon, B Schmitz, P House, et al.
Neurology|September 26, 1997
Refined mapping of the epilepsy susceptibility locus EJM1 on chromosome 6T Sander, B Bockenkamp, T Hildmann, et al.
Pageof 24